Evidence map›Paper›PMID 34885681›Full record

ArticleMolecules (Basel, Switzerland)2021

Evaluation of the Antioxidant and Antiradical Properties of Some Phyto and Mammalian Lignans.

Leyla Polat Kose, İlhami Gulcin

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
4.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Antioxidants: a comprehensive review.Archives of toxicology · 2025
    Review
  9. Bioactive Lignan Glycosides in Stems of Marsh Rosemary (Antioxidants (Basel, Switzerland) · 2025
    Article
  10. Review
  11. Review
  12. From Traditional Amazon Use to Food Applications:Foods (Basel, Switzerland) · 2025
    Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Potential antioxidant, anticholinergic, antidiabetic and antiglaucoma activities and molecular docking of spiraeoside as a secondary metabolite of onion (Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2023
    Article
  19. A New Lignan fromMolecules (Basel, Switzerland) · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Leyla Polat KoseDepartment of Pharmacy Services, Vocational School, Beykent University, Istanbul 34500, Turkey.
İlhami GulcinDepartment of Chemistry, Faculty of Science, Ataturk University, Erzurum 25240, Turkey.ORCID 0000-0001-5993-1668
Atatürk University · TRBeykent University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, the antioxidant and antiradical properties of some phyto lignans (nordihydroguaiaretic acid, secoisolariciresinol, secoisolariciresinol diglycoside, and α-(-)-conidendrin) and mammalian lignans (enterodiol and enterolactone) were examined by different antioxidant assays. For this purpose, radical scavenging activities of phyto and mammalian lignans were realized by 2,2'-azino-bis (3-ethylbenzothiazoline-6-sulphonic acid) radical (ABTS

Indexed as

AnimalsAntioxidantsBenzothiazolesBiphenyl CompoundsButylated HydroxyanisoleButylated HydroxytolueneButylene GlycolsChromansCopperFree Radical ScavengersIonsIronLignansLipid PeroxidationMammalsMasoprocol1,1-diphenyl-2-picrylhydrazyl2,2'-azino-di-(3-ethylbenzothiazoline)-6-sulfonic acid6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acidAntioxidantsBenzothiazolesBiphenyl CompoundsButylated HydroxyanisoleButylated HydroxytolueneButylene GlycolsChromansconidendrinCopperFree Radical ScavengersIonsIronLignansMasoprocolPhytochemicalsPicratessecoisolariciresinolSulfonic AcidsTetrahydronaphthalenesantioxidant activityantiradical activitylignanphenolic compoundsreducing power

Identifiers

PMID34885681
PMCPMC8659077
OpenAlexW3217212004

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.